Position in MRVI
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$18,106,645
+$11,233,376 QoQ
Shares Held
2,901,706
+19.5% QoQ
Ownership
1.12%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 177 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. MRVI ranks #168 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,106,645 | 2,901,706 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $6,873,269 | 2,428,717 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,846,309 | 2,414,249 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,850,776 | 2,387,030 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,738,959 | 2,381,311 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,026,126 | 2,726,754 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $15,155,343 | 2,780,797 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,858,923 | 2,750,773 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,812,514 | 2,767,111 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $17,654,495 | 2,036,274 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $13,200,660 | 2,015,368 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $18,074,990 | 1,807,499 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $22,802,747 | 1,834,493 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $25,784,956 | 1,840,468 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $25,875,184 | 1,808,189 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $44,804,537 | 1,754,976 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $49,685,908 | 1,748,888 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $63,849,880 | 1,810,317 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $67,418,482 | 1,609,033 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $68,067,825 | 1,386,875 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $50,926,624 | 1,220,384 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $23,113,573 | 648,529 | Shares | Defined | 2021-07-09 | |
| No filing history on record for this holder in this stock. | ||||||